Security record · archived quarter
PAHC
Phibro Animal Health Corporation · Healthcare · Drug Manufacturers - Specialty & Generic
10Tracked holders
—Δ holders
1.66MShares held
$27.80MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 76 | -16 | 15.41M | $484.55M | +5 | −21 |
| Q1 2026 | 95 | +6 | 14.51M | $800.97M | +11 | −5 |
| Q4 2025 | 89 | +1 | 14.47M | $540.64M | +1 | — |
| Q3 2025 | 17 | +1 | 9.22M | $372.92M | +1 | — |
| Q2 2025 | 13 | +1 | 8.13M | $207.65M | +2 | −1 |
| Q1 2025 | 9 | 0 | 3.02M | $64.46M | +1 | −1 |
| Q4 2024 | 9 | -1 | 3.00M | $62.94M | — | −1 |
| Q3 2024 | 9 | -1 | 1.81M | $40.65M | — | −1 |
| Q2 2024 | 10 | — | 1.66M | $27.80M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 526.80K | — | $8.83M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 480.27K | — | $8.06M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 480.27K | — | $8.06M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | AQR Capital Management ✦ | 183.21K | — | $3.07M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 183.21K | — | $3.07M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 183.21K | — | $3.07M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 151.85K | — | $2.55M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 117.35K | — | $1.97M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 117.35K | — | $1.97M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 66.19K | — | $1.11M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 63.06K | — | $1.06M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 30.09K | — | $504,693 | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 22.73K | — | $381,182 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 15.92K | — | $268,000 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 255 holders, 20.06M shares, $1.03B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Aug 06
SC 13G/A — FMR LLC
Jul 30
SC 13G — MILLENNIUM MANAGEMENT LLC
May 22
SC 13D/A — BFI Co., LLC
48.2% of class · View original SEC filing ↗
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API